Year-end Report 2022 Redsense Medical AB (publ)
Back-to-back order records give tailwind for 2023 October – December 2022 · Net sales amounted to kSEK 8,027 (4,109), an increase of 95.3 percent. · Operating profit, EBIT amounted to kSEK 555 (-2,582). · Result after tax amounted to kSEK -2,297 (-1,421). · Earnings per share was SEK -0.16 (-0.10) before and after dilution. January – December 2022 · Net sales amounted to kSEK 14,340 (9,362), an increase of 53.2 percent. · Operating loss, EBIT amounted to kSEK 10,208 (11,991). · Result after tax amounted to kSEK -8,758 (-7,972). · Earnings per share was SEK -